Lv7
5008 积分 2021-12-16 加入
Anti–PD-1 antibodies recognizing the membrane-proximal region are PD-1 agonists that can down-regulate inflammatory diseases
13小时前
已完结
Antibody cocktails based on the occupationally acquired immunity of pediatricians neutralize and confer protection against RSV and hMPV
4个月前
已完结
A novel anti-HER2/EGFR bispecific antibody–drug conjugate demonstrates promising antitumor efficacy and overcomes resistance to HER2- or EGFR-targeted ADCs
5个月前
已完结
Design, synthesis and evaluation of novel 1,3-benzodioxole derivatives for their anti-tumor activity
5个月前
已完结
Type 2 immunity: Expanding our view
6个月前
已完结
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
6个月前
已完结
Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)
6个月前
已完结
An “Fc-Silenced” IgG1 Format With Extended Half-Life Designed for Improved Stability
6个月前
已完结
A Novel Designed Anti–PD-L1/OX40 Bispecific Antibody Augments Both Peripheral and Tumor-Associated Immune Responses for Boosting Antitumor Immunity
6个月前
已完结
An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
6个月前
已完结
皖公网安备34019202002308
